{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T08:25:31Z","timestamp":1776846331034,"version":"3.51.2"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T00:00:00Z","timestamp":1748563200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01LM013771"],"award-info":[{"award-number":["R01LM013771"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biomedical Informatics"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.jbi.2025.104859","type":"journal-article","created":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T20:32:10Z","timestamp":1748723530000},"page":"104859","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A trajectory-informed model for detecting drug-drug-host interaction from real-world data"],"prefix":"10.1016","volume":"168","author":[{"given":"Yi","family":"Shi","sequence":"first","affiliation":[]},{"given":"Anna","family":"Sun","sequence":"additional","affiliation":[]},{"given":"Hongmei","family":"Nan","sequence":"additional","affiliation":[]},{"given":"Yuedi","family":"Yang","sequence":"additional","affiliation":[]},{"given":"Jing","family":"Xu","sequence":"additional","affiliation":[]},{"given":"Michael T","family":"Eadon","sequence":"additional","affiliation":[]},{"given":"Jing","family":"Su","sequence":"additional","affiliation":[]},{"given":"Pengyue","family":"Zhang","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/j.jbi.2025.104859_b0005","unstructured":"CDC: Centers for Disease Control and Prevention, FastStats: Medication Safety Data, 2024, Available from: https:\/\/www.cdc.gov\/medication-safety\/data-research\/facts-stats\/index.html."},{"issue":"4","key":"10.1016\/j.jbi.2025.104859_b0010","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1111\/bcp.15970","article-title":"Drug-drug interactions and the risk of adverse drug reaction-related hospital admissions in the older population","volume":"90","author":"Hughes","year":"2024","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"5","key":"10.1016\/j.jbi.2025.104859_b0015","doi-asserted-by":"crossref","first-page":"604","DOI":"10.3325\/cmj.2011.52.604","article-title":"Adverse drug reactions caused by drug-drug interactions reported to Croatian Agency for Medicinal Products and Medical Devices: a retrospective observational study","volume":"52","author":"Mirosevic Skvrce","year":"2011","journal-title":"Croat. Med. J."},{"issue":"1","key":"10.1016\/j.jbi.2025.104859_b0020","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12874-023-01885-w","article-title":"Statistical methods for exploring spontaneous adverse event reporting databases for drug-host factor interactions","volume":"23","author":"Lu","year":"2023","journal-title":"BMC Med Res Methodol"},{"issue":"11","key":"10.1016\/j.jbi.2025.104859_b0025","first-page":"1867","article-title":"Gender differences, polypharmacy, and potential pharmacological interactions in the elderly","volume":"66","author":"Venturini","year":"2011","journal-title":"Clinics (Sao Paulo)"},{"issue":"1","key":"10.1016\/j.jbi.2025.104859_b0030","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/cpt.277","article-title":"Pharmacoepidemiologic methods for studying the health effects of drug-drug Interactions","volume":"99","author":"Hennessy","year":"2016","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.jbi.2025.104859_b0035","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/cpt.1376","article-title":"A case-crossover-based screening approach to identifying clinically relevant drug-drug Interactions in electronic healthcare data","volume":"106","author":"Bykov","year":"2019","journal-title":"Clin Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.jbi.2025.104859_b0040","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/BF03256929","article-title":"Potential drug-drug interactions associated with prolonged stays in the intensive care unit: a retrospective cohort study","volume":"31","author":"Moura","year":"2011","journal-title":"Clin Drug Investig"},{"issue":"4","key":"10.1016\/j.jbi.2025.104859_b0045","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1002\/sim.7545","article-title":"Mixture drug-count response model for the high-dimensional drug combinatory effect on myopathy","volume":"37","author":"Wang","year":"2018","journal-title":"Stat. Med."},{"issue":"2","key":"10.1016\/j.jbi.2025.104859_b0050","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/cpt.1631","article-title":"The self-controlled case series design as a viable alternative to studying clinically relevant drug Interactions","volume":"107","author":"Zhou","year":"2020","journal-title":"Clin. Pharmacol. Ther."},{"issue":"125","key":"10.1016\/j.jbi.2025.104859_b0055","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3003377","article-title":"Data-driven prediction of drug effects and interactions","volume":"4","author":"Tatonetti","year":"2012","journal-title":"Sci. Transl. Med."},{"issue":"2","key":"10.1016\/j.jbi.2025.104859_b0060","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1097\/EDE.0000000000000944","article-title":"The case-crossover design for drug-drug interactions: considerations for implementation","volume":"30","author":"Bykov","year":"2019","journal-title":"Epidemiology"},{"issue":"1","key":"10.1016\/j.jbi.2025.104859_b0065","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1080\/10543406.2013.736810","article-title":"Likelihood ratio test-based method for signal detection in drug classes using FDA's AERS database","volume":"23","author":"Huang","year":"2013","journal-title":"J. Biopharm. Stat."},{"issue":"7","key":"10.1016\/j.jbi.2025.104859_b0070","doi-asserted-by":"crossref","first-page":"623","DOI":"10.2165\/00002018-200730070-00011","article-title":"Bayesian confidence propagation neural network","volume":"30","author":"Bate","year":"2007","journal-title":"Drug Saf."},{"issue":"16","key":"10.1016\/j.jbi.2025.104859_b0075","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.1002\/sim.3247","article-title":"A statistical methodology for drug-drug interaction surveillance","volume":"27","author":"Noren","year":"2008","journal-title":"Stat. Med."},{"issue":"27","key":"10.1016\/j.jbi.2025.104859_b0080","doi-asserted-by":"crossref","first-page":"5088","DOI":"10.1002\/sim.10216","article-title":"A Precision mixture risk model to identify adverse drug events in subpopulations using a case-crossover design","volume":"43","author":"Shi","year":"2024","journal-title":"Stat. Med."},{"issue":"7","key":"10.1016\/j.jbi.2025.104859_b0085","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1002\/sim.8457","article-title":"Propensity score-adjusted three-component mixture model for drug-drug interaction data mining in FDA adverse event reporting system","volume":"39","author":"Wang","year":"2020","journal-title":"Stat. Med."},{"key":"10.1016\/j.jbi.2025.104859_b0090","first-page":"281","article-title":"Statistical mining of potential drug interaction adverse effects in FDA's spontaneous reporting system","volume":"2010","author":"Harpaz","year":"2010","journal-title":"AMIA Annu. Symp. Proc."},{"issue":"5","key":"10.1016\/j.jbi.2025.104859_b0095","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1109\/JBHI.2018.2874533","article-title":"Mining directional drug interaction effects on myopathy using the FAERS database","volume":"23","author":"Chasioti","year":"2019","journal-title":"IEEE J. Biomed. Health Inform."},{"key":"10.1016\/j.jbi.2025.104859_b0100","unstructured":"U. Patel, et al. Validation of acute kidney injury cases in the mini-sentinel distributed database. 10\/04\/2022]; Available from: https:\/\/www.sentinelinitiative.org\/sites\/default\/files\/Drugs\/Assessments\/Mini-Sentinel_Validation-of-Acute-Kidney-Injury-Cases.pdf."},{"key":"10.1016\/j.jbi.2025.104859_b0105","unstructured":"U.S. Food and Drug Administration (FDA). Gastrointestinal Bleed Algorithm Defined in \u201cStroke, Gastrointestinal Bleeding, and Intracranial Hemorrhage following Apixaban or Warfarin Use in Patients with Non-Valvular Atrial Fibrillation: a Propensity Score Matched Analysis, 2019; Available from: https:\/\/www.sentinelinitiative.org\/sites\/default\/files\/surveillance-tools\/validations-literature\/GI_Bleed_apixaban_final_codelist.pdf."},{"issue":"3","key":"10.1016\/j.jbi.2025.104859_b0110","doi-asserted-by":"crossref","first-page":"233","DOI":"10.7861\/clinmedicine.13-3-233","article-title":"Identification of risk factors associated with acute kidney injury in patients admitted to acute medical units","volume":"13","author":"Finlay","year":"2013","journal-title":"Clin Med (lond)"},{"issue":"4","key":"10.1016\/j.jbi.2025.104859_b0115","doi-asserted-by":"crossref","first-page":"c179","DOI":"10.1159\/000339789","article-title":"KDIGO clinical practice guidelines for acute kidney injury","volume":"120","author":"Khwaja","year":"2012","journal-title":"NephronClin Pract"},{"issue":"Suppl 1","key":"10.1016\/j.jbi.2025.104859_b0120","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1007\/s40264-013-0097-8","article-title":"Defining a reference set to support methodological research in drug safety","volume":"36","author":"Ryan","year":"2013","journal-title":"Drug Saf"},{"issue":"3","key":"10.1016\/j.jbi.2025.104859_b0125","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1080\/00031305.1999.10474456","article-title":"Bayesian data mining in large frequency tables, with an application to the FDA spontaneous reporting system","volume":"53","author":"DuMouchel","year":"1999","journal-title":"Am. Stat."},{"issue":"13","key":"10.1016\/j.jbi.2025.104859_b0130","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1002\/sim.3586","article-title":"Bayesian pharmacovigilance signal detection methods revisited in a multiple comparison setting","volume":"28","author":"Ahmed","year":"2009","journal-title":"Stat. Med."},{"issue":"7","key":"10.1016\/j.jbi.2025.104859_b0135","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s40264-022-01191-2","article-title":"Comment on: \u201cdrug-drug Interaction of the sodium glucose co-transporter 2 inhibitors with statins and myopathy: a disproportionality analysis using adverse events reporting data\u201d","volume":"45","author":"Noguchi","year":"2022","journal-title":"Drug Saf"},{"issue":"1","key":"10.1016\/j.jbi.2025.104859_b0140","doi-asserted-by":"crossref","first-page":"13693","DOI":"10.1038\/s41598-025-98528-5","article-title":"A theoretical model for detecting drug interaction with awareness of timing of exposure","volume":"15","author":"Shi","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.jbi.2025.104859_b0145","article-title":"A theoretical model for detecting drug interaction with awareness of timing of exposure","author":"Shi","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jbi.2025.104859_b0150","unstructured":"Side Effect Resource (SIDER 4.1). Available from: http:\/\/sideeffects.embl.de\/."},{"key":"10.1016\/j.jbi.2025.104859_b0155","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ejim.2022.05.003","article-title":"Acute kidney injury associated with non-steroidal anti-inflammatory drugs","volume":"101","author":"Klomjit","year":"2022","journal-title":"Eur J Intern Med"},{"issue":"6","key":"10.1016\/j.jbi.2025.104859_b0160","doi-asserted-by":"crossref","first-page":"e1514","DOI":"10.1097\/MJT.0000000000000221","article-title":"Effect of omeprazole on the pharmacokinetics of rosuvastatin in healthy male volunteers","volume":"23","author":"Shah","year":"2016","journal-title":"Am J Ther"},{"issue":"3","key":"10.1016\/j.jbi.2025.104859_b0165","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s13318-014-0211-z","article-title":"Pharmacokinetic study of rosuvastatin in males and females","volume":"40","author":"Nazir","year":"2015","journal-title":"Eur J Drug Metab Pharmacokinet"},{"issue":"5","key":"10.1016\/j.jbi.2025.104859_b0170","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/clpt.2008.150","article-title":"Warfarin with fluoroquinolones, sulfonamides, or azole antifungals: interactions and the risk of hospitalization for gastrointestinal bleeding","volume":"84","author":"Schelleman","year":"2008","journal-title":"Clin Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.jbi.2025.104859_b0175","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1007\/s10557-022-07346-8","article-title":"Simvastatin, but not atorvastatin, is associated with higher peak Rivaroxaban serum levels and bleeding: an asian cohort study from Singapore","volume":"37","author":"Soh","year":"2023","journal-title":"CardioVasc Drugs Ther"},{"issue":"3","key":"10.1016\/j.jbi.2025.104859_b0180","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.giec.2015.02.010","article-title":"Epidemiology and risk factors for upper gastrointestinal bleeding","volume":"25","author":"Tielleman","year":"2015","journal-title":"Gastrointest Endosc Clin N Am"},{"key":"10.1016\/j.jbi.2025.104859_b0185","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ejim.2018.11.003","article-title":"Mortality rate and risk factors for gastrointestinal bleeding in elderly patients","volume":"61","author":"Lenti","year":"2019","journal-title":"Eur J Intern Med"},{"issue":"49\u201350","key":"10.1016\/j.jbi.2025.104859_b0190","doi-asserted-by":"crossref","first-page":"705","DOI":"10.4414\/smw.2007.11912","article-title":"Risk factors for gastrointestinal bleeding: a hospital-based case-control study","volume":"137","author":"Vonbach","year":"2007","journal-title":"Swiss Med Wkly"},{"key":"10.1016\/j.jbi.2025.104859_b0195","doi-asserted-by":"crossref","unstructured":"Strate, L.L., et al. Risk factors for mortality in lower intestinal bleeding. Clin Gastroenterol Hepatol 6(9) (2008) 1004-10; quiz 955-.","DOI":"10.1016\/j.cgh.2008.03.021"},{"issue":"4","key":"10.1016\/j.jbi.2025.104859_b0200","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1111\/j.1365-2125.2012.04446.x","article-title":"Predicted metabolic drug clearance with increasing adult age","volume":"75","author":"Polasek","year":"2013","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"10.1016\/j.jbi.2025.104859_b0205","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.mcpdig.2024.03.005","article-title":"Deep learning-based prediction modeling of major adverse cardiovascular events after liver transplantation","volume":"2","author":"Abdelhameed","year":"2024","journal-title":"Mayo Clin Proc Digit Health"}],"container-title":["Journal of Biomedical Informatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1532046425000887?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1532046425000887?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T07:29:22Z","timestamp":1776842962000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1532046425000887"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":41,"alternative-id":["S1532046425000887"],"URL":"https:\/\/doi.org\/10.1016\/j.jbi.2025.104859","relation":{},"ISSN":["1532-0464"],"issn-type":[{"value":"1532-0464","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A trajectory-informed model for detecting drug-drug-host interaction from real-world data","name":"articletitle","label":"Article Title"},{"value":"Journal of Biomedical Informatics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbi.2025.104859","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"104859"}}